Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 infection can significantly cause temporary hair loss.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

A specific laser treatment can promote hair growth in mice by increasing certain protein levels.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Your genes, especially IL-1a, can predict how well a hair growth treatment with platelet rich plasma will work for you.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Adapalene 0.1% effectively reduces acne by decreasing comedones and altering skin properties.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Melatonin improves cashmere goat hair quality by increasing follicles and reducing skin aging.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

COVID-19 infection may cause hair loss.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

The hydrogel with a 1:3 ratio of hydroxyethyl cellulose to hyaluronic acid is effective for delivering drugs through the skin to treat acne.

Some drugs may help treat both COVID-19 and radiation injury.

PRP treatment may help with alopecia areata, especially in newer cases.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.